lorazepam has been researched along with Drug Refractory Epilepsy in 2 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Excerpt | Relevance | Reference |
---|---|---|
" Five patients were sedated with initial lorazepam dose, but this side effect resolved on dosage reduction." | 1.72 | Enteral lorazepam is a promising weaning strategy for midazolam-responsive febrile infection-related epilepsy syndrome (FIRES): a case series ( Chaitra, R; Jain, V; Konanki, R; Sharma, R; Srivastava, K, 2022) |
" Our objective was to evaluate BZD dosing in SE patients and its effects on clinical/electrographic outcomes." | 1.48 | Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus. ( Ibrahim, M; Mahulikar, A; Mohamed, W; Rao, SK; Seraji-Bozorgzad, N; Shah, A, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Jain, V | 1 |
Konanki, R | 1 |
Chaitra, R | 1 |
Srivastava, K | 1 |
Sharma, R | 1 |
Rao, SK | 1 |
Mahulikar, A | 1 |
Ibrahim, M | 1 |
Shah, A | 1 |
Seraji-Bozorgzad, N | 1 |
Mohamed, W | 1 |
2 other studies available for lorazepam and Drug Refractory Epilepsy
Article | Year |
---|---|
Enteral lorazepam is a promising weaning strategy for midazolam-responsive febrile infection-related epilepsy syndrome (FIRES): a case series
Topics: Child; Drug Resistant Epilepsy; Encephalitis; Epileptic Syndromes; Humans; Lorazepam; Male; Midazola | 2022 |
Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus.
Topics: Adult; Aged; Anticonvulsants; Benzodiazepines; Coma; Disease Progression; Drug Resistant Epilepsy; F | 2018 |